Literature DB >> 11231209

Use of medical chemoprophylaxis and antimosquito precautions in Danish malaria patients and their traveling companions.

I Mølle1, K L Christensen, P S Hansen, U B Dragsted, M Aarup, M R Buhl.   

Abstract

BACKGROUND: The number of malaria cases imported to Denmark has been increasing for some years. To analyze the background for this we assessed the use of protective measures in Danish travelers visiting malarious areas.
METHOD: Post-travel questionnaires were given during hospitalization to malaria patients, and sent by mail to their traveling companions.
RESULTS: In total, 142 persons participated. Only 32% of the travelers used chemoprophylaxis correctly, according to Danish recommendations. Twelve percent of the travelers did not use chemoprophylaxis. Average compliance was 52%. Insufficient drug dosage was reported by 13%, and use of nonrecommended drugs by 7% of the travelers. Thirty-seven percent used insufficient antimosquito precautions, a problem which often coincided with irregular use of chemoprophylaxis. Malaria patients, sole travelers, and travelers with other ethnical background than Danish, were subgroups using insufficient malaria prophylaxis more frequently than healthy traveling companions.
CONCLUSION: Insufficient use of the available antimalaria precautions by Danish travelers contributes greatly to maintaining a high incidence of imported malaria. Increased attention from physicians in educating travelers is important for optimizing malaria prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11231209     DOI: 10.2310/7060.2000.00074

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  5 in total

1.  Pharmaceutical care model to assess the medication-related risks of travel.

Authors:  Ian M Heslop; Michelle Bellingan; Richard Speare; Beverley D Glass
Journal:  Int J Clin Pharm       Date:  2014-10-01

2.  Determinants of compliance with anti-vectorial protective measures among non-immune travellers during missions to tropical Africa.

Authors:  Emmanuel Sagui; Noémie Resseguier; Vanessa Machault; Lénaïck Ollivier; Eve Orlandi-Pradines; Gaetan Texier; Frédéric Pages; Remy Michel; Bruno Pradines; Sébastien Briolant; Alain Buguet; Catherine Tourette-Turgis; Christophe Rogier
Journal:  Malar J       Date:  2011-08-10       Impact factor: 2.979

Review 3.  Mefloquine for preventing malaria during travel to endemic areas.

Authors:  Maya Tickell-Painter; Nicola Maayan; Rachel Saunders; Cheryl Pace; David Sinclair
Journal:  Cochrane Database Syst Rev       Date:  2017-10-30

4.  Summary of recommendations for the prevention of malaria by the Committee to Advise on Tropical Medicine and Travel (CATMAT).

Authors:  A Boggild; J Brophy; P Charlebois; M Crockett; J Geduld; W Ghesquiere; P McDonald; P Plourde; P Teitelbaum; M Tepper; S Schofield; A McCarthy
Journal:  Can Commun Dis Rep       Date:  2014-04-03

5.  Malaria risk in travelers.

Authors:  Helena Hervius Askling; Jenny Nilsson; Anders Tegnell; Ragnhild Janzon; Karl Ekdahl
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.